Evidence map›Paper›PMID 34652421›Full record

ArticleThe Journal of cell biology2021

Tyrosine phosphorylation of S1PR1 leads to chaperone BiP-mediated import to the endoplasmic reticulum.

Mumtaz Anwar, Md Ruhul Amin, Vijay Avin Balaji Ragunathrao, Jacob Matsche, Andrei Karginov, Richard D Minshall, Gary C H Mo, Yulia Komarova, Dolly Mehta

Open access · greenAbstract read
In one paragraph

Article in The Journal of cell biology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.4field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Mumtaz AnwarDepartment of Pharmacology, Center for Lung and Vascular Biology, College of Medicine, University of Illinois at Chicago, Chicago, IL.ORCID 0000-0001-5711-7312
Md Ruhul AminDepartment of Pharmacology, Center for Lung and Vascular Biology, College of Medicine, University of Illinois at Chicago, Chicago, IL.
Vijay Avin Balaji RagunathraoDepartment of Pharmacology, Center for Lung and Vascular Biology, College of Medicine, University of Illinois at Chicago, Chicago, IL.ORCID 0000-0001-6032-4048
Jacob MatscheDepartment of Pharmacology, Center for Lung and Vascular Biology, College of Medicine, University of Illinois at Chicago, Chicago, IL.
Andrei KarginovDepartment of Pharmacology, Center for Lung and Vascular Biology, College of Medicine, University of Illinois at Chicago, Chicago, IL.ORCID 0000-0003-2370-6383
Richard D MinshallDepartment of Pharmacology, Center for Lung and Vascular Biology, College of Medicine, University of Illinois at Chicago, Chicago, IL.ORCID 0000-0003-3164-475X
Gary C H MoDepartment of Pharmacology, Center for Lung and Vascular Biology, College of Medicine, University of Illinois at Chicago, Chicago, IL.
Yulia KomarovaDepartment of Pharmacology, Center for Lung and Vascular Biology, College of Medicine, University of Illinois at Chicago, Chicago, IL.ORCID 0000-0002-3526-6082
Dolly MehtaDepartment of Pharmacology, Center for Lung and Vascular Biology, College of Medicine, University of Illinois at Chicago, Chicago, IL.ORCID 0000-0003-0945-9304
University of Illinois Chicago · US

Funding

TRPC6 Regulation of Lung Endothelial Barrier FunctionP01HL060678 · NHLBI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI MALIK, ASRAR B. · 2000 to 2020
$40.1M
Focal Adhesion Kinase Regulation of Lung Vascular Permeability and EdemagenesisR01HL084153 · NHLBI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI MEHTA, DOLLY · 2007 to 2022
$5.4M
Mechanisms of endothelial regeneration and resolution of lung vascular injuryR01HL137169 · NHLBI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI MEHTA, DOLLY · 2017 to 2020
$2.1M
Fibroblast Mediated Mechanisms of Pulmonary HypertensionR01HL142636 · NHLBI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI MINSHALL, RICHARD D · 2019 to 2023
$2.0M
NHLBI NIH HHS P01 HL060678NHLBI NIH HHS R01 HL084153NHLBI NIH HHS R01 HL137169NHLBI NIH HHS R01 HL142636NIH HHS HL84153
6 · The paper itself

Abstract

Cell surface G protein-coupled receptors (GPCRs), upon agonist binding, undergo serine-threonine phosphorylation, leading to either receptor recycling or degradation. Here, we show a new fate of GPCRs, exemplified by ER retention of sphingosine-1-phosphate receptor 1 (S1PR1). We show that S1P phosphorylates S1PR1 on tyrosine residue Y143, which is associated with recruitment of activated BiP from the ER into the cytosol. BiP then interacts with endocytosed Y143-S1PR1 and delivers it into the ER. In contrast to WT-S1PR1, which is recycled and stabilizes the endothelial barrier, phosphomimicking S1PR1 (Y143D-S1PR1) is retained by BiP in the ER and increases cytosolic Ca2+ and disrupts barrier function. Intriguingly, a proinflammatory, but non-GPCR agonist, TNF-α, also triggered barrier-disruptive signaling by promoting S1PR1 phosphorylation on Y143 and its import into ER via BiP. BiP depletion restored Y143D-S1PR1 expression on the endothelial cell surface and rescued canonical receptor functions. Findings identify Y143-phosphorylated S1PR1 as a potential target for prevention of endothelial barrier breakdown under inflammatory conditions.

Indexed as

CytosolEndocytosisEndoplasmic ReticulumEndoplasmic Reticulum Chaperone BiPEndothelial CellsHumansInflammationPhosphorylationProteolysisReceptors, G-Protein-CoupledSphingosine-1-Phosphate ReceptorsTumor Necrosis Factor-alphaTyrosineEndoplasmic Reticulum Chaperone BiPReceptors, G-Protein-CoupledS1PR1 protein, humanSphingosine-1-Phosphate ReceptorsTumor Necrosis Factor-alphaTyrosine

Identifiers

PMID34652421
PMCPMC8562845
OpenAlexW3205943041

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.